MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/aos.13491

Медицинская библиотека · Acta ophthalmologica · 2017

Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study.

Schwartz Roy, Habot-Wilner Zohar, Martinez Michael R, Nutman Amir, Goldenberg Dafna, Cohen Shai, Shulman Shiri, Guzner-Gur Hanan, Loewenstein Anat, Goldstein Michaella

СтатьяПеревод в очереди

Аннотация

PURPOSE: To evaluate the efficacy and safety of eplerenone for chronic nonresolving central serous chorioretinopathy (CSC).

METHODS

Prospective, double-blind, randomized placebo-controlled study. Nineteen eyes of 17 patients with persistent subretinal fluid (SRF) due to CSC were enrolled and randomized to receive eplerenone 50 mg/day or placebo for 3 months, followed by a 3-month follow-up. The main outcome measure was change in SRF from baseline to 3 months of treatment. Secondary outcomes included change in SRF at any time-point, complete resolution of SRF, improvement in choroidal thickness and change in best-corrected visual acuity (BCVA).

RESULTS

Thirteen eyes were treated with eplerenone and six with placebo. Both groups showed reduction in SRF throughout the treatment period, with a significant reduction at months 1, 3 and 5 only in the treatment group. Twenty-three per cent in the treatment group and 30.8% per cent in the placebo group experienced complete resolution of SRF. A significant improvement in BCVA was noted in the placebo group at 4 months, as well as a significant difference in BCVA between groups at 3 months in favour of the placebo group (p = 0.005). There was no significant difference in choroidal thickness in either group throughout the study period. No adverse events related to eplerenone were noted in the treatment group.

CONCLUSION

In this study, eplerenone was not found to be superior to placebo in eyes with chronic CSC.

Для цитирования: Schwartz Roy, Habot-Wilner Zohar, Martinez Michael R, Nutman Amir, Goldenberg Dafna, Cohen Shai, Shulman Shiri, Guzner-Gur Hanan, Loewenstein Anat, Goldstein Michaella. Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study.. Acta ophthalmologica. 2017. DOI: 10.1111/aos.13491.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.